This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sinovac Biotech Ltd (SVA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 91.52M 107.24M 91.24M 104.29M
Receivables 40.76M 31.93M 23.44M 17.83M
Inventories 18.83M 14.33M 10.53M 8.11M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 154.80M 157.25M 126.28M 132.04M
Property, Plant & Equipment, Gross 102.82M 95.42M 101.13M 91.65M
Accumulated Depreciation & Depletion 34.40M 27.46M 21.05M 16.02M
Property, Plant & Equipment, Net 68.42M 67.96M 80.08M 75.63M
Intangibles 352.00K 772.00K 1.15M 1.34M
Other Non-Current Assets 14.44M 14.59M 801.74K 6.49M
Total Non-Current Assets 83.73M 83.44M 82.48M 83.87M
Liabilities & Shareholder Equity
Total Assets 238.53M 240.69M 208.76M 215.91M
Accounts Payable 14.16M 17.07M 15.24M 22.75M
Short Term Debt 49.97M 19.54M 3.33M 4.71M
Other Current Liabilities 2.37M 3.00M 2.69M 6.80M
Total Current Liabilities 79.83M 49.16M 30.15M 40.64M
Long Term Debt 1.80M 32.15M 31.18M 17.32M
Deferred Income Taxes 0.00 0.00 4.07M 0.00
Other Non-Current Liabilities 15.17M 15.75M 13.92M 12.65M
Minority Interest 515.00K 2.93M -3.90M 445.00K
Total Non-Current Liabilities 32.13M 62.85M 60.88M 45.34M
Total Liabilities 111.97M 112.01M 91.04M 85.99M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 126.56M 128.68M 117.72M 129.92M
Common Par 56.00K 56.00K 55.09K 54.77K
Additional Paid In Capital 108.24M 107.39M 106.25M 117.19M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -6.38M -4.71M -12.16M 2.70M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 24.65M 25.95M 23.58M 9.98M
Total Capitalization 128.37M 160.83M 148.91M 147.24M
Total Equity 126.56M 128.68M 117.72M 129.92M
Total Liabilities & Stock Equity 238.53M 240.69M 208.76M 215.91M
Total Common Shares Outstanding 55.81M 55.57M 55.09M 54.77M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 55.68M 55.30M 54.93M 54.61M
Diluted Weighted Shares Outstanding 55.68M 55.80M 54.93M 54.61M
Number of Employees 556 715 652 614
Number of Part-Time Employees 112 0 0 0
SVA News

SVA Sinovac Biotech Ltd

Chart of SVA

Analysts Ratings for SVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SVA ANALYST REPORT

Brokerage Partners

SVA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs